Investing Profile

Colleen Cuffaro

VCInvestor
Partner at Canaan Partners
canaan.com/team/colleen-cuffa...New Haven, Connecticut
Photo of Colleen Cuffaro, Partner at Canaan Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Pennsylvania Network
135 CONNECTIONS
Canaan Partners Network
15 CONNECTIONS
cb
$250K - $20.0M
$10.0M
9
$800M
CompanyStageDateRound SizeTotal Raised
AgomAb Therapeutics
Series COct 2023$100M
$200M
Co-investors: Ohad Hammer (Pontifax Venture Capital), Felice Verduyn - van Weegen (EQT Life Sciences), Iyona Rajkomar (Pontifax Venture Capital)
Comet Therapeutics
Series AJun 2019$29M
$29M
Co-investors: Roel Bulthuis (INKEF Capital), Henrijette Richter (Soffinova Partners)
Arrakis Therapeutics
Series BApr 2019$75M
Series AFeb 2017$38M
$110M
Co-investors: Jakob Loven (Nextech Invest), Richard Gaster (venBio)
NextCure
Series BNov 2018$93M
Series AJan 2016$67M
$160M
Co-investors: Tim Shannon (Canaan Partners), David Kabakoff (HealthQuest Capital)
Arvinas
Series CApr 2018$55M
Series BOct 2015$42M
Series ASep 2013$15M
$110M
Co-investors: Tim Shannon (Canaan Partners), Stephen Squinto (OrbiMed), Kush Parmar (5am Ventures), Liam Ratcliffe (Access Biotechnology), Andrew Levin (RA Capital), Jakob Loven (Nextech Invest), Daniel Wagner (Connecticut Innovations)
Associate Canaan Partners2014 - Present
Bio Sciences Analyst Entrepreneurship Lab NYC2012 - 2013
Analytical Chemist PMRS Inc2006 - 2009
Yale University School of Medicine PhD Cellular and Molecular Physiology
University of Pennsylvania BA Chemistry